Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Single-Centre Study. (PubMed, Asia Pac J Clin Oncol) - Sep 11, 2026 - "In this first Australian study examining all forms of cancer, ICI-AKI occurred infrequently, but had a significant clinical impact. Ipilimumab exposure and impaired baseline kidney function were key risk factors."
Checkpoint inhibition • Journal • Acute Kidney Injury • Nephrology • Oncology • Renal Disease
|
|
Caroline Milton; Jyothirmaye Kuppa; Nitesh Rao; Rajiv Juneja; Shahid Ullah
|